MICB and neoplasm: The production of MICA and MICB by virus-infection or tumor cells has been previously reported [19,20], and the ability of these ligands to induce cytotoxic activity in NK cells and other cytotoxic lymphocytes through the interaction with their cognate receptor, NKG2D, has been well established [21,22].